PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Pharmacy, Science for Life Laboratory, Uppsala University, Uppsala, Sweden.\', \'Department of Clinical Sciences, Karolinska Institute, Danderyd Hospital, Stockholm, Sweden.\', \'Department of Medical Cell Biology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden.\', \'Department of Oncology-Pathology, Karolinska Institute, Stockholm, Sweden.\', \'Department of Immunology, Genetics, and Pathology, Uppsala University, Uppsala, Sweden.\', \'Division of Affinity Proteomics, Department of Protein Science, KTH Royal Institute of Technology, Science for Life Laboratory, Stockholm, Sweden.\', \'Department of Medicine Huddinge, Karolinska Institute, Centre for Infectious Medicine, Stockholm, Sweden.\', \'Division of Protein Technology, Department of Protein Science, KTH Royal Institute of Technology, Stockholm, Sweden.\', \'Department of Neuroscience, Uppsala University, Uppsala, Sweden.\', \'SciCross AB, Skövde, Sweden.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1002/iid3.595
?:doi
?:hasPublicationType
?:journal
  • Immunity, inflammation and disease
is ?:pmid of
?:pmid
?:pmid
  • 35349756
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • 3
?:title
  • Long-term SARS-CoV-2-specific and cross-reactive cellular immune responses correlate with humoral responses, disease severity, and symptomatology.
?:type
?:year
  • 2022

Metadata

Anon_0  
expand all